Pear Therapeutics

Entity > Corporation > US > New York City New York > Pear Therapeutics

About Pear Therapeutics

Pear Therapeutics Inc. is a biotechnology and software company providing digital therapeutic platforms to treat disease and improve drug efficacy. Its commercial products are reSET for the treatment of substance use disorder related to alcohol, cannabis, cocaine, and stimulants.

Pear Therapeutics, Inc. Offers Prescription Digital Therapeutics (PDTs): Prescription digital therapeutics from Pear Therapeutics are software-based treatments for diseases in therapeutic areas such as psychiatric and neurological disorders. Pear Therapeutics was the first company in the world to receive Food and Drug Administration (FDA) approval for PDTs, which are claimed to improve clinical outcomes of diseases.

Pear Therapeutics, Inc. Has The First Three PDTs Approved By the FDA To Treat Diseases: Pear Therapeutics' first product, reSET, for the treatment of substance use disorders, was the first PDT to receive FDA approval for the treatment of disease. The second product, reSET-O, for the treatment of opioid use disorder, was the first PDT to receive Breakthrough Designation. The third product, Somryst, for the treatment of chronic insomnia, was the first PDT submitted through the FDA's traditional 510(k) pathway and simultaneously reviewed under the FDA's Software Precertification Pilot Program.

Founding: Pear Therapeutics, Inc. is headquartered in Boston, Massachusetts, and was founded in 2013 by Corey McCann, Stephen Smith, and William Greene.

Industry: Business & Industrial > Pharmaceuticals & Biotech

More information about Pear Therapeutics

Company Attribute Value
Address StreetAddress: 200 State St, AddressLocality: Boston, AddressRegion: Massachusetts, PostalCode: 2109, AddressCountry: United States
Founding Date 2013
Name Pear Therapeutics
Number Of Employees 300
Revenue $6,581,000 USD
Ticker Symbol NASDAQ: PEAR
Url peartherapeutics
Facebook facebook
Linkedin linkedin
Twitter twitter
Google google
Wikidata wikidata

Pear Therapeutics


New York City, US
7 Sep 2023

New York City, US
7 Sep 2023

Pear Therapeutics

Page: 1 Desktop | Laptop Devices › medtech › pear-pulpe...
Pear Therapeutics apps sell for $6M in post-bankruptcy ...
May 19, 2023 — Click Therapeutics—itself a developer of apps to help treat migraine, smoking cessation, depression and more—offered $70,000 for the patents ... › view
What Does Pear Therapeutics' Bankruptcy Mean for PDTs?
Jun 9, 2023 — Pear Therapeutics Inc. was a pioneer in digital therapeutics — and prescription digital therapeutics in particular — so when the ... › company › pear-therapeut...
Pear Therapeutics
Jan 3, 2022 — Pear is the leader in developing and commercializing software-based medicines, called prescription digital therapeutics (PDTs). Pear aims to ... › katiejennings › 2023/04/07
Pear Therapeutics Files For Bankruptcy As CEO Blames ...
Apr 7, 2023 — P ear Therapeutics, which has three FDA-cleared prescription apps to help treat substance use disorder and insomnia, filed for bankruptcy on ... › organization › pear-the...
Pear Therapeutics - Crunchbase Company Profile & Funding
Pear Therapeutics is a software-based digital therapeutics platform designed to treat disease and enhance the efficacy of pharmaceuticals. › health-tech-deals › 2023/05/22
Pear Therapeutics sold for parts
May 22, 2023 — Digital therapeutics company Pear Therapeutics was sold for parts to four companies for a combined $6.05 million in an auction last week. › 2023/05/19 › pear-therap...
Pear Therapeutics sold for parts at $6 million auction
May 19, 2023 — Founded in 2013, Pear was the most prominent company developing prescription digital therapeutics, or Food and Drug Administration-cleared ... › digital › pears-demise-si...
Is Pear's demise a sign of things to come for digital ...
Apr 19, 2023 — As Pear Therapeutics' financial situation forces the company into bankruptcy, Ben Hargreaves takes a look at whether this is just a blip on ... › news › qa-digital-t...
Q&A: Digital therapeutics' future after the fall of Pear ...
May 12, 2023 — Since Pear Therapeutics, one of the earliest digital therapeutic companies, declared bankruptcy in April, there's been discussion ... › news › pear-thera...
Pear Therapeutics files for bankruptcy
Apr 7, 2023 — Pear Therapeutics, maker of prescription digital therapeutics, announced today that it has filed for Chapter 11 bankruptcy and is seeking a ...
Related Searches
Related Searches
pear therapeutics news
pear therapeutics products
Pear therapeutics fda approval
Knowledge Panel
Knowledge Panel

Pear Therapeutics, Inc. (Commercial company)

Pear Therapeutics is a software-based digital therapeutics platform designed to treat disease and enhance the efficacy of pharmaceuticals. Boston, Massachusetts, United States. 101-250. Post-IPO Equity. Public.,Public
  • Stock price : PEARQ (OTCMKTS) $0.00 0.00 (0.00%)Sep 6, 4:00 PM EDT - Disclaimer
  • Founded : 2013
  • Headquarters : Boston, MA
  • Ceo : CEO Corey McCann

All information on this page is taken from publicly available sources, and the analysis we provide is a representation of Google's search results for the entity and does not represent any opinion or judgement about the entity by Kalicube itself. If you disagree with this analysis, please contact us and cite this reference : 134196